ArticlePaediatric and perinatal epidemiology2026
Maternal Haemoglobin and Haematocrit During Pregnancy and Stillbirth Risk: A Prospective, Population-Based Birth Cohort Study.
Article in Paediatric and perinatal epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Right-sizing Incentives.Journal of development economics · 2026Article
- Maternal Haemoglobin and Haematocrit During Pregnancy and Stillbirth Risk: A Prospective, Population-Based Birth Cohort Study.Paediatric and perinatal epidemiology · 2026Article
- Maternal Haemoglobin and Stillbirth Risk: Implications for Policy and Practice.Paediatric and perinatal epidemiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundMaternal anaemia is a public health issue globally, associated with adverse maternal and neonatal outcomes. However, less is known about the effects of high haemoglobin (Hb) and haematocrit (Hct) on the risk of stillbirth.
objectivesWe assessed the dose-response effects of dynamic changes in maternal Hb and Hct across all trimesters on stillbirth risk.
methodsThis study was based on the prospective, longitudinal, population-based China birth cohort study (CBCS) between 2018 and 2022, including 142,715 women with live births or stillbirths delivered at ≥ 20 weeks' gestation. The modified Poisson regression models were used to assess the association between Hb/Hct, haemodilution status across three trimesters and stillbirth.
resultsOver a fifth (23.6%) of pregnant women had anaemia at least once during pregnancy. Maternal anaemia increased the risk of stillbirth. The adjusted risk ratio (aRR) for Hb at 70-99 g/L (moderate anaemia) was 2.45, 95% confidence interval (CI) 1.26, 4.76 and aRR for Hct < 33% (anaemia) was 1.63 (95% CI 1.12, 2.38) in the first trimester. Interestingly, a U-shaped association between Hb/Hct and stillbirth was observed, and high Hb/Hct levels in any of the three trimesters were related to increased stillbirth risk. Excessive haemoglobin dilution/haemoglobin concentration across trimesters was also associated with higher stillbirth risk, especially from the first to the second trimesters, with aRRs of 1.86 (95% CI 1.15, 3.01) and 3.34 (95% CI 2.08, 5.37), respectively.
conclusionsConsidering the U-shaped association between Hb/Hct levels and stillbirth, clinical vigilance is necessary at both low- and high-extremes of Hb/Hct and physiological haemodilution metrics in mid-to-late pregnancy for improved pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.